(2H-1,3-benzodioxol-5-yl)boronic acid → HCID 69585120, Verbindung
Reaktionsgleichung
[N+:1]([C:4]1[CH:5]=[C:6]([C:12]2[O:13][C:14]3[CH:20]=[CH:19][C:18](Br)=[CH:17][C:15]=3[N:16]=2)[C:7]([O:10][CH3:11])=[CH:8][CH:9]=1)([O-:3])=[O:2].[CH2:22]1[O:30][C:29]2[CH:28]=[CH:27][C:26](B(O)O)=[CH:25][C:24]=2[O:23]1>>[N+:1]([C:4]1[CH:5]=[C:6]([C:12]2[O:13][C:14]3[CH:20]=[CH:19][C:18]([C:27]4[CH:26]=[CH:25][C:24]5[O:23][CH2:22][O:30][C:29]=5[CH:28]=4)=[CH:17][C:15]=3[N:16]=2)[C:7]([O:10][CH3:11])=[CH:8][CH:9]=1)([O-:3])=[O:2]Komponenten
3
Versuchsvorschrift
Prepared by the method of Example 15d), from 2-(3-nitro-6-methoxyphenyl)-5-bromobenzoxazole (400 mg, 1.14 mmol) and 3,4-methylenedioxyphenylboronic acid (285 mg, 1.71 mmol) the subtitle compound was obtained (270 mg, 48%). The product was used directly in the next step without purification.
Quellen und Nachweise
- ORD-Eintrag
- ord-312e562e05e14a9093948404c6f1c68f
- Quelldatensatz
- uspto-grants-2006_11